Navegar por término MeSH "Drug Resistance"

Mostrando ítems 1-14 de 14

As resistencias a antimicrobianos nos últimos anos: De Europa a Galicia

2015-
Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: a qualitative study from Spain.

2012-06- LOPEZ VAZQUEZ, PAULA; Vázquez Lago, Juan Manuel; Figueiras Guzmán, Adolfo; Lopez Durán, Ana; Taracido-TrunK, Margarita [et al.]
Combination of KIR2DS4 and FcgammaRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

2019- Borrero-Palacios, A; Cebrian, A; Gomez Del Pulgar, M T; Garcia-Carbonero, R; Garcia-Alfonso, P; [et al.]
Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer. Spanish TTD Group Expert Opinion.

2020- Fernández Montes, Ana; Grávalos, Cristina; Pericay, Carles; Safont, Ma José; Benavides, Manuel; [et al.]
Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains of Klebsiella pneumoniae

2020- Bleriot Rial, Ines Maria; TRASTOY PENA, ROCIO; Blasco Otero, Lucía; Fernández-Cuenca, Felipe; Ambroa, Antón; [et al.]
In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens

2020- Blasco Otero, Lucía; Ambroa Abalo, Antón; TRASTOY PENA, ROCIO; Bleriot Rial, Ines Maria; Moscoso Naya, Miriam; [et al.]
Involvement of HisF in the Persistence of Acinetobacter baumannii During a Pneumonia Infection

2019- Martínez Guitian, Marta; Vázquez Ucha, Juan Carlos; Alvarez Fraga, Laura; Conde Pérez, Kelly; Lasarte Monterrubio, Cristina; [et al.]
Kpi, a chaperone-usher pili system associated with the worldwide-disseminated high-risk clone Klebsiella pneumoniae ST-15

2020- Gato Corral, Eva; Vázquez Ucha, Juan Carlos; Rumbo Feal, Soraya; Alvarez Fraga, Laura; Vallejo Vidal, Juan Andrés; [et al.]
Marine Organisms from the Yucatan Peninsula (Mexico) as a Potential Natural Source of Antibacterial Compounds

2020- Pech Puch, Dawrin Jesús; Pérez Povedano, Mar; Gómez, Patricia; Martínez Guitian, Marta; Lasarte Monterrubio, Cristina; [et al.]
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

2019- Penalver, F. J.; Marquez, J. A.; Duran, S.; Giraldo, P.; Martin, A.; [et al.]
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: Implications for clinical practice

2019- Alvarez, M.; Casas, P.; De Salazar, A.; Chueca, N.; Guerrero-Beltran, C.; [et al.]
The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models

2019- Gomez-Miragaya, J.; Moran, S.; Calleja-Cervantes, M. E.; Collado-Sole, A.; Pare, L.; [et al.]
The STOP-AB trial protocol: efficacy and safety of discontinuing patient antibiotic treatment when physicians no longer consider it necessary

2017- Llor, Carl; Moragas, Ana; Bayona, Carolina; Cots, Josep M; Molero, José M; [et al.]
Variation in antibiotic prescription rates in febrile children presenting to emergency departments across Europe (MOFICHE): A multicentre observational study

2020- Hagedoorn, N. N.; Borensztajn, D. M.; Nijman, R.; Balode, A.; von Both, U.; [et al.]